Walpar Nutritions Limited
Fixed Price IPO · NSE
- Price band
- ₹55 - ₹55
- Lot size
- 2,000 shares
- Issue amount
- ₹7 cr
- Total subscription
- 0×
- Opens
- 30 Jun 2021
- Closes
- 5 Jul 2021
- Allotment
- 8 Jul 2021
- Listing
- 13 Jul 2021
Offer at a glance
Issue overview
- Issue size
- 12,00,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,10,000
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹0 cr
- Registrar
- Skyline Financial Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,10,000
- Issue type
- Fixed Price IPO
- Shares before issue
- 33,41,220
- Shares after issue
- 45,41,220
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 2,000 | ₹1,10,000 |
| HNI | 2 | 4,000 | ₹2,20,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
Walpar Nutritions, founded in 2009, manufactures a wide range of health and wellness products including nutraceuticals, ayurvedic remedies, skincare, sexual wellness products, and food supplements. The company has developed over 100 formulations and more than 1,000 brands across categories such as bone and joint care, heart and diabetes management, skin care, pain relief, women’s health, brain and nerve support, digestion, and sports nutrition. Its products are made in various forms including tablets, capsules, creams, gels, powders, liquids, and sachets at its manufacturing facility in Gandhinagar, which has a monthly capacity of 23 lakh tablets, 12.5 lakh capsules, 1.5 lakh oral liquid bottles, and 2 lakh sachets.
Strengths
- Wide Range of Products: Offers a big portfolio with 70+ health and wellness products .
- Strong in Manufacturing & Innovation: Skilled at both making and developing new products .
- Trusted Quality: All products are FSSAI and AYUSH certified , ensuring top-notch quality and safety.
Promoters
Mr. Kalpesh Pravinchandra Ladhawala
Mr. Tanmay Kumar Ashwinbhai
Mrs. Sejal Kalpesh Ladhawala
Registrar & documents
Lead manager
Beeline Capital Advisors Private Limited
Registrar & contacts
Skyline Financial Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
2nd Floor, L5: 377 PLOT:5, Opp. Sabarmati, Village Taluka kalol, Gandhinagar-382721
+91 94277 12047
[email protected]Company website ↗Frequently Asked Questions
What is Walpar Nutritions IPO GMP today?
Currently, Walpar Nutritions IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹55. Track daily updates on IPO Premiums as bidding numbers unfold.
What is the lot size and minimum investment for Walpar Nutritions IPO?
The minimum bid lot size for Walpar Nutritions IPO is 2,000 shares. At the cut-off price of ₹55 per share, retail investors need a minimum application amount of ₹1,10,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Walpar Nutritions IPO allotment status be announced?
The allotment status for Walpar Nutritions IPO is scheduled to be finalized on 8 Jul 2021. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Skyline Financial Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Walpar Nutritions IPO allotment status online by PAN?
To check Walpar Nutritions IPO allotment status: 1) Visit the registrar portal (Skyline Financial Services Private Limited) or the BSE IPO allotment page. 2) Select 'Walpar Nutritions Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.